MT-8421

· Molecular Templates, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-8421, covering 2024-11-01 to 2024-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types [Phase 1]

See pricing